Transdermal delivery of methotrexate for pediatrics using silicon microneedles

Therapeutic Delivery

Volumn 4, Issue 5, 2013, Pages 543-551

  Abla, Mehtab J ^a   Chaturvedula, Ayyappa ^a   O'Mahony, Conor ^b   Banga, Ajay K ^a  

^a MERCER UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCEIN; METHOTREXATE; METHYLENE BLUE; PREDNISONE; SILICON;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DERMATOMYOSITIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ELECTROPORATION; IN VITRO STUDY; MAINTENANCE DRUG DOSE; MALE; MICRONEEDLE; NONHUMAN; OSTEOSARCOMA; PEDIATRICS; PERMEABILITY BARRIER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RHEUMATOID ARTHRITIS; SCANNING ELECTRON MICROSCOPY; SKIN IRRITATION; SKIN PERMEABILITY; SKIN WATER LOSS; STRATUM CORNEUM;

EID: 84877650064     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.13.24     Document Type: Article

References (29)

1. Nunn T, Williams J. Formulation of medicines for children. Br. J. Clin. Pharmacol. 59(6), 674-676 (2005
2. Shah UU, Roberts M, Gul M, Tuleu C, Beresford MW. Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs). Int. J. Pharm. 416(1), 1-11(2011
3. Prausnitz MR, Langer R. Transdermal drug delivery. Nat. Biotechnol. 26(11), 1261-1268 (2008
4. Roxhed N, Samel B, Nordquist L, Griss P, Stemme G. Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Trans. Biomed. Eng. 55(3), 1063-1071 (2008
5. Chen B, Wei J, Iliescu C. Sonophoretic enhanced microneedles array (SEMA)- Improving the efficiency of transdermal drug delivery. Sens. Actuators B Chem. 145(1), 54-60 (2010
6. Banga AK. Microporation applications for enhancing drug delivery. Expert Opin. Drug Deliv. 6(4), 343-354 (2009
7. Wilke N, Reed M, Morrissey A. The evolution from convex corner undercut towards microneedle formation: theory and experimental verification. J. Micromech. Microeng. 16, 808-814 (2006
8. Kalluri H, Kolli CS, Banga AK. Characterization of microchannels created by metal microneedles: formation and closure. AAPS J. 13(3), 473-481 (2011
9. Dadlani C, Orlow SJ. Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J. Am. Acad. Dermatol. 52(2), 316-340 (2005
10. Patino-Garcia A, Zalacain M, Marrodan L, San-Julian M, Sierrasesumaga L. Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression. J. Pediatr. 154(5), 688-693 (2009
11. Vemulapalli V, Yang Y, Friden PM, Banga AK. Synergistic effect of iontophoresis and soluble microneedles for transdermal delivery of methotrexate. J. Pharm. Pharmacol. 60(1), 27-33 (2008
12. Haq MI, Smith E, John DN et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed. Microdevices 11(1), 35-47 (2009
13. Kolli CS, Banga AK. Characterization of solid maltose microneedles and their use for transdermal delivery. Pharm. Res. 25(1), 104-113 (2008
14. Kalluri H, Banga AK. Formation and closure of microchannels in skin following microporation. Pharm. Res. 28(1), 82-94 (2011
15. Li G, Badkar A, Nema S, Kolli CS, Banga AK. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int. J. Pharm. 368(1-2), 109-115 (2009
16. Colom H, Farre R, Soyet D et al. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma. Ther. Drug Monit. 31(1), 76-85 (2009
17. Donnelly RF, Singh TR, Tunney MM et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm. Res. 26(11), 2513-2522 (2009
18. Li G, Badkar A, Kalluri H, Banga AK. Microchannels created by sugar and metal microneedles: characterization by microscopy, macromolecular flux and other techniques. J. Pharm. Sci. 99(4), 1931-1941 (2010
19. Netzlaff F, Kostka KH, Lehr CM, Schaefer UF. TEWL measurements as a routine method for evaluating the integrity of epidermis sheets in static Franz type diffusion cells in vitro. Limitations shown by transport data testing. Eur. J. Pharm. Biopharm. 63(1), 44-50 (2006
20. Al-Qallaf B, Das DB. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery. Ann. NY Acad. Sci. 1161, 83-94 (2009
21. Enfield J, O'Connell ML, Lawlor K, Jonathan E, O'Mahony C, Leahy M. In vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. J. Biomed. Opt. 15 (4), 046001(2010
22. Kelly A, Ramanan AV. The principles of pharmacological treatment of juvenile idiopathic arthritis. Paediatr. Child Health (Oxford) 21(12), 563-568 (2011
23. Quartier P. Current treatments for juvenile idiopathic arthritis. Joint Bone Spine 77(6), 511-516 (2010
24. Kugathasan S, Newman AJ, Dahms BB, Boyle JT. Liver biopsy findings in patients with juvenile rheumatoid arthritis receiving long-term, weekly methotrexate therapy. J. Pediatr. 128(1), 149-151 (1996
25. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J. Pediatr. 134(1), 47-52 (1999
26. Vagace JM, de la Maya MD, Caceres- Marzal C, Murillo S, Gervasini G. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma. Crit. Rev. Oncol. Hematol. 84(2), 274-286 (2012
27. Ramanan AV, Campbell-Webster N, Ota S et al. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Arthritis Rheum. 52(11), 3570-3578 (2005
28. Kellie SJ, Wong CK, Pozza LD et al. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a Phase II study in newly diagnosed children. Med. Pediatr. Oncol. 39(3), 168-174 (2002
29. Truven health analytics. www.micromedex.com (Accessed 10 December 2012